Chong Kun Dang Pharmaceutical Corp. (185750.KS) KSC

81,200.00

+400(+0.50%)

Updated at August 22 03:30PM

Currency In KRW

Valuation

Market Cap1.18T
Enterprise Value1.14T
P/E Ratio11.23
PEG Ratio-0.88
Price/Sales Ratio0.66
Price/Book Ratio1.2
Enterprise/Revenue0.64
Enterprise/EBITDA4.8

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0.06
Operating Margin0.05

Management Effectiveness

Return On Assets0.06
Return On Equity0.11

Income Statement

Revenue1.59T
Revenue/Share123,359.97
Gross Profit532.61B
EBITDA150.03B
Net Income109.07B
Diluted EPS8,206.52

Balance Sheet

Total Cash283.7B
Total Cash/Share21,525.05
Total Debt187.44B
Total Debt/Equity0.21
Current Ratio2.5
Book Value Per Share67,735.92

Price History

52-Week Change-30.17
52-Week High124,000
52-Week Low70,900
Moving Average 50 Days84,150
Moving Average 200 Days84,152.41

Statistics

Average Volume42,683
Shares Outstanding13.18M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate1,047.62
Trailing Annual Dividend Yield1.29
Payout Ratio0.14
Last Split Factor21:20
Last Split DateDecember 27, 2024